118 related articles for article (PubMed ID: 6474081)
1. Antigen-antibody complexes in inflammatory bowel disease.
Danis VA; Harries AD; Heatley RV
Scand J Gastroenterol; 1984 Jul; 19(5):603-6. PubMed ID: 6474081
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulins (Ig) in circulating immune complexes (CIC) in cancer and inflammatory bowel disease (IBD).
Shafir M; Martinelli G; Bekesi JG; Jaramillo S; Heimann T; Aufses AH
Eur J Surg Oncol; 1986 Dec; 12(4):351-7. PubMed ID: 3780988
[TBL] [Abstract][Full Text] [Related]
3. Detection of rheumatoid factors of different isotypes and of circulating immune complexes in patients with inflammatory bowel disease.
Procaccia S; Bianchi Porro G; Colucci A; Villa P; Blasio R; Ardizzone S; Bonacina CA; Zanussi C
Boll Ist Sieroter Milan; 1990 Jun; 69(2):413-21. PubMed ID: 2152301
[TBL] [Abstract][Full Text] [Related]
4. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
5. Evidence against the presence of circulating immune complexes in chronic inflammatory bowel disease.
Soltis RD; Hasz D; Morris MJ; Wilson ID
Gastroenterology; 1979 Jun; 76(6):1380-5. PubMed ID: 155547
[TBL] [Abstract][Full Text] [Related]
6. Enhanced superoxide anion release of normal neutrophil granulocytes primed with sera of patients with inactive inflammatory bowel disease.
Griga T; Tromm A; Schwegler U; May B
Z Gastroenterol; 1995 Jul; 33(6):345-8. PubMed ID: 7668025
[TBL] [Abstract][Full Text] [Related]
7. Immune complexes in ulcerative colitis and Crohn's disease.
Hodgson HJ; Potter BJ; Jewell DP
Clin Exp Immunol; 1977 Aug; 29(2):187-96. PubMed ID: 908171
[TBL] [Abstract][Full Text] [Related]
8. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody 1F10 immunoreactivity in inflammatory bowel disease: a new marker specific only for continuous endothelial cells.
Lügering N; Stoll R; Holzgreve A; Winde G; Sorg C; Domschke W
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):777-81. PubMed ID: 7496869
[TBL] [Abstract][Full Text] [Related]
10. Alterations in serum anti-alpha-galactosyl antibodies in patients with Crohn's disease and ulcerative colitis.
D'Alessandro M; Mariani P; Lomanto D; Bachetoni A; Speranza V
Clin Immunol; 2002 Apr; 103(1):63-8. PubMed ID: 11987986
[TBL] [Abstract][Full Text] [Related]
11. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB
Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
[TBL] [Abstract][Full Text] [Related]
12. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
[TBL] [Abstract][Full Text] [Related]
13. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
[TBL] [Abstract][Full Text] [Related]
14. Circulating Clq binding complexes in inflammatory bowel diseases.
Einstein E; Charland C; Thayer WR
Digestion; 1979; 19(1):65-9. PubMed ID: 456771
[TBL] [Abstract][Full Text] [Related]
15. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
16. Tissue carcinoembryonic antigen, dysplasia, and disease duration in colonic inflammatory bowel disease.
Greenstein AJ; Panvelliwalla DK; Katz LB; Heimann TM; Donnelly J; Pertsimlidis D; Geller S; Smith H; Aufses AH
Am J Gastroenterol; 1982 Apr; 77(4):212-5. PubMed ID: 7072691
[TBL] [Abstract][Full Text] [Related]
17. Measles IgM immunoreactivity in patients with inflammatory bowel disease.
Balzola FA; Khan K; Pera A; Bonino F; Pounder RE; Wakefield AJ
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):378-82. PubMed ID: 9789132
[TBL] [Abstract][Full Text] [Related]
18. Serum gastrin levels in patients with inflammatory bowel disease.
Triantafillidis JK; Tzourmakliotis D; Peros G; Merikas E; Barbatzas C; Cheracakis P; Gikas A; Konstandellou E
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cccxv-cccxvii. PubMed ID: 15244213
[TBL] [Abstract][Full Text] [Related]
19. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
20. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]